Esophageal Strictures

Introduction

Introduction to Esophageal Stricture

Overview

Esophageal stricture refers to the abnormal narrowing of the esophageal lumen, leading to dysphagia, or difficulty swallowing. This condition arises from various causes, such as inflammation, fibrosis, or neoplasia, damaging the mucosal or submucosal layers of the esophagus. These strictures can be either benign or malignant, necessitating accurate diagnosis for effective management.

Etiology

The predominant cause of esophageal strictures in adults is benign peptic stricture, accounting for 70-80% of cases, typically associated with long-standing gastroesophageal reflux disease (GERD). The preventive use of proton pump inhibitors (PPIs) has reduced the incidence of peptic strictures. Other factors contributing to esophageal stricture include:

  • Acid peptic damage
  • Autoimmune disorders
  • Infectious diseases
  • Caustic substance ingestion
  • Congenital factors
  • Iatrogenic causes (medical interventions)
  • Medication-induced damage
  • Radiation therapy
  • Malignant growths
  • Idiopathic (unknown) causes

Pathophysiology and Prognosis

The development of an esophageal stricture is a gradual process. Its prognosis largely depends on the timely evaluation and management, along with the underlying cause of the stricture.

Management and Challenges

The primary treatment for benign esophageal strictures is esophageal dilation. However, this method carries a 10-30% risk of re-stenosis, or recurrence of the stricture. Recurrent strictures pose significant challenges, including increased risks and healthcare costs.

Epidemiology

Epidemiology of Esophageal Stricture

Incidence and Prevalence

  • General Incidence: Esophageal stricture has an incidence rate of 1.1 per 10,000 person-years, with an increase in incidence observed with advancing age.
  • Study Findings: In one study, the overall incidence was reported as 11 per 100,000 individuals, with benign strictures at 8 per 100,000 and malignant strictures at 3 per 100,000.

Impact of Diagnostic Delay

  • Eosinophilic Esophagitis (EoE): The prevalence of esophageal stricture increases with delayed diagnosis, ranging from 17% within 0-2 years to 71% after 20 years.

Age-Related Variations

  • Children and Young Patients: Higher incidence of strictures due to caustic esophagitis or eosinophilic esophagitis.
  • Adults: Acid reflux, iatrogenic, or drug-induced esophagitis are more common causes.
  • Older Populations: Increased incidence of malignant strictures due to higher cancer prevalence.

Influence of GERD

  • GERD-Related Strictures: Approximately 7-23% of untreated GERD patients develop esophageal strictures.
  • GERD Prevalence: Affects about 40% of adults, with strictures in 7–23% of untreated cases.
  • Impact of Proton Pump Inhibitors: The incidence of benign esophageal stricture has decreased due to PPI use in GERD treatment.

Gender and Racial Distribution

  • Gender Differences: Higher risk in men under 60 years, but similar incidence in men and women after age 60.
  • Racial Predilection: No racial predilection has been identified for esophageal stricture.

Etiology

Etiology of Esophageal Stricture

Intrinsic Diseases

  • Gastroesophageal Reflux Disease (GERD): The most common intrinsic cause, accounting for 70-80% of adult cases. Chronic reflux of stomach acid into the esophagus leads to inflammation, scarring, and eventually narrowing.
  • Eosinophilic Esophagitis: An allergic inflammatory condition causing esophageal narrowing.
  • Radiation Therapy: Can induce inflammation and scarring, leading to stricture.
  • Esophageal Varices Treatment: Procedures like banding or sclerotherapy may result in injury and stricture.
  • Caustic Ingestions: Corrosive substance ingestion leads to severe injury and stricture.
  • Esophageal Surgeries: Post-operative scarring can cause stricture.
  • Nasogastric Tube Use: Frequent use may cause injury and stricture.
  • Dermatologic Diseases: Rare conditions involving the esophagus.
  • Congenital Factors: Esophageal strictures and webs present from birth.

Extrinsic Diseases

  • Malignancies and Lymph Node Enlargement: Direct invasion or lymph node enlargement can compress the esophagus, causing stricture.

Disorders Affecting Esophageal Motility

  • Conditions that disrupt esophageal movement and lower esophageal sphincter function.

Pathogenesis

Pathogenesis of Esophageal Stricture

Inflammation and Fibrosis

  • GERD: Chronic regurgitation of gastric contents into the esophagus leads to inflammation and fibrosis of the esophageal mucosa, causing stricture. Contributing factors include esophageal dysmotility, lower esophageal sphincter (LES) tone impairment, transient LES relaxation, and delayed gastric emptying.
  • Eosinophilic Esophagitis (EoE): A chronic, T helper type 2 (Th2)–associated inflammatory disease marked by eosinophilic inflammation. Its pathogenesis involves environmental and genetic factors, with roles for eosinophils, mast cells, and cytokines like IL-5 and IL-13, often triggered by allergic sensitization to foods.
  • Caustic Ingestion: Ingesting toxic substances (like lye) severely damages the esophageal mucosa, leading to inflammation, necrosis, and subsequent fibrosis and stricture.

Neoplasia

  • Tumor Growth: Abnormal cell growth can cause stricture either through direct invasion of the esophageal lumen or extrinsic compression by enlarged lymph nodes or other structures.

Other Contributing Factors

  • Autoimmune Diseases
  • Infectious Diseases
  • Congenital Conditions
  • Iatrogenic Causes (medical interventions)
  • Medication-Induced Causes
  • Radiation-Induced Causes
  • Idiopathic Processes (unknown causes)

Signs and Symptoms

Signs and Symptoms of Esophageal Stricture

Common Symptoms

  • Dysphagia: Difficulty swallowing is the most common symptom.
  • Odynophagia: Painful swallowing.
  • Regurgitation: Food coming back up the throat from the stomach.
  • Heartburn: Frequent occurrence.
  • Throat Inflammation: Burning sensation in the throat.
  • Hiccupping/Burping: Frequent episodes.
  • Coughing/Choking: Especially during eating.
  • Weight Loss: Unintentional, due to difficulty in swallowing.
  • Drooling: Inability to swallow saliva efficiently.
  • Dehydration: Due to difficulty in swallowing liquids.

Diagnosis

Diagnosis of Esophageal Stricture

Initial Evaluation

  • Medical History: Understanding symptoms like dysphagia, food sticking sensation, and heartburn.
  • Physical Examination: Bedside evaluation for signs indicative of esophageal stricture.

Diagnostic Tests

  • Esophagogastroduodenoscopy (EGD): A flexible tube with a camera is used to visualize the esophagus, stomach, and duodenum. It helps identify the stricture’s presence and location. Biopsies can be performed if needed.
  • Contrast-enhanced Esophagogram or Barium Swallow: Patient swallows a barium solution to coat the esophagus, making it visible on X-rays. This shows the size and location of the stricture.
  • Esophageal Manometry: Measures esophageal muscle pressure and coordination, detecting irregular peristalsis or muscle contractions.
  • Endoscopic Ultrasound (EUS): Useful particularly when biopsies are negative for malignancy but there’s suspicion of esophageal cancer.

Assessment of Esophageal Motility Disorders

  • It’s important to evaluate for any associated esophageal motility disorders, as they can influence the management approach for esophageal strictures.

Differential Diagnosis

Differential Diagnosis of Esophageal Stricture

Key Conditions to Consider

  • Achalasia: A disorder affecting esophageal motility and relaxation of the lower esophageal sphincter.
  • Esophageal Motility Disorders: Abnormal muscle contractions in the esophagus causing dysphagia.
  • Esophagitis: Inflammation of the esophagus, which can mimic symptoms of stricture.
  • Schatzki Ring: A thin ring of tissue in the lower esophagus that can cause swallowing difficulties.
  • Plummer-Vinson Syndrome: Characterized by iron deficiency anemia, dysphagia, and esophageal webs.
  • Diffuse Esophageal Spasm: Intermittent contractions of the esophagus leading to swallowing issues.
  • Systemic Sclerosis: An autoimmune disease that can involve esophageal dysfunction.
  • Zenker’s Diverticulum: A pouch that can form in the throat, near the esophagus, causing swallowing difficulties.
  • Esophageal Carcinoma: Cancer of the esophagus, presenting with progressive dysphagia.
  • Stroke: Neurological event that can affect swallowing.
  • Motor Disorders: Such as Myasthenia Gravis, affecting muscle strength and function.
  • Gastroesophageal Reflux Disease (GERD): Chronic acid reflux causing esophageal irritation.
  • Esophageal Web: Thin membranes across the esophagus, causing obstruction.

Treatment

Treatment Options for Esophageal Stricture

Esophageal Dilation

  • Procedure: Widening the narrowed area using a balloon or dilator.
  • Method: Placement of the dilator using an endoscope, often performed during endoscopy.

Steroid Injections

  • Purpose: To reduce inflammation and prevent recurrence of the stricture.
  • Application: Administered alongside dilation procedures.

Stent Placement

  • Use: Primarily for palliation of malignant esophageal strictures.
  • Function: Keeps the esophagus open to facilitate swallowing, suited for patients with limited expected survival.

Incisional Therapy

  • Indication: For refractory strictures that do not respond to dilation.
  • Method: Cutting scar tissue to open the stricture.

Surgical Resection

  • Consideration: In cases involving cancer, to remove cancerous tissue.
  • Goal: To alleviate the stricture caused by tumor growth.

Medical Management

  • Treatment: Use of proton pump inhibitors (PPIs) for underlying conditions like GERD.
  • Objective: To prevent further damage and recurrence of the stricture.

Dilation

Esophageal Dilation

Evaluation Prior to Esophageal Dilation

Barium Studies

  • General Use: Not typically required before endoscopy in suspected esophageal stricture cases.
  • Specific Cases: Recommended for complex strictures, such as those from radiation therapy or caustic ingestion.
  • Goals: Identify stricture location, length, number, esophageal lumen diameter, and any associated pathology.
  • Purpose: Helps in selecting dilating techniques, estimating session numbers, and informing patients about risks.

Endoscopy

  • Role in Malignancy: Necessary for diagnosis if barium studies suggest malignancy.
  • Typical Procedure: Often performed along with dilation in the initial session.

Contraindications to Dilation

  • Acute Conditions: Avoid in acute or incompletely healed esophageal perforation.
  • Malignancy Concerns: Postpone if the stricture might be malignant, until confirmed benign.
  • Comorbid Illnesses: Consider risks in patients with bleeding disorders or severe pulmonary/cardiovascular disease.
  • Special Cases: Use caution in patients with pharyngeal or cervical deformities, recent surgery, large thoracic aneurysms, or impacted food bolus.
  • Eosinophilic Esophagitis: Extreme care needed due to higher perforation risk.

Types of Esophageal Dilators

Mechanical Dilators

  • Categories: Push-type (Bougie) and balloon dilators.
  • Mechanism: Increase esophageal lumen size through stretching or splitting.
  • Types:
    • Freely Passed Dilators: Maloney (common, tapered tip, multiple sizes, mercury or tungsten-filled), Hurst (rounded tip, less common). Pasted-20231202-150932.svg
    • Guidewire-Assisted Dilators: Savary-Gilliard (plastic, tapered, multiple sizes), American Dilatation System, Eder-Puestow olive dilators (metal, less used). Pasted-20231202-151058.svg
    • Flexible Bougie: Transparent, over endoscope, allows sequential dilation.

Balloon Dilators

  • Types: Through-the-scope (TTS) and over-the-guidewire (OTW).
  • Features: Greater radial force, retain maximum diameter predictably.
  • Sizes: Initially in 2 mm increments, newer TTS balloons expand to three diameters at 1.0 to 1.5 mm increments.

Therapeutic Approach to Esophageal Stricture

Approach Based on Stricture Characteristics

  • Dependency: Treatment varies depending on the stricture’s nature and the endoscopist’s experience.
  • Simple vs. Complex: Simple strictures differ significantly from complex ones in terms of management.

Treatment of Simple Strictures

  • Characteristics: Typically associated with prolonged reflux esophagitis, they are smooth, short, straight, and located in the distal esophagus.
  • Diameter Consideration: Can be traversed with an endoscope (>10 mm in diameter).
  • Dilation Techniques: Use of Maloney dilators, balloon dilators, or mechanical dilators passed over a guidewire, based on preference.

Treatment of Complex Strictures

  • Nature: Long, narrow, tortuous, or associated with other complications like hiatal hernias or diverticula.
  • Risk Mitigation: Use of a guidewire-based system or a balloon dilator to prevent complications like esophageal perforation.
  • Combination Therapy: Initial dilation with guidewire or balloon dilators, followed by Maloney dilators for further sessions if feasible.

Special Considerations

  • Proximal Strictures: May require a barium swallow for detailed assessment. Treated with guidewire-based dilators, sometimes under fluoroscopic guidance.
  • Eosinophilic Esophagitis (EoE): Dilation as adjunctive therapy after medical treatment fails. Increased risk of tearing and perforation. Both mechanical and balloon dilators are used without a clear superiority. Aim for symptomatic relief with a maximum diameter of 13 to 14 mm.

Perforation Risk in EoE

  • Systematic Review Findings: Relative risk of perforation in EoE dilation is 0.1 percent, similar to other indications.

Dilation Technique

Procedure Overview

  • Setting: Performed as an ambulatory procedure using conscious sedation and topical pharyngeal anesthesia.
  • Patient Preparation: Fasting, avoidance of antiplatelet agents and anticoagulants, no longer requiring antibiotic prophylaxis.
  • Positioning: Left lateral decubitus position; seated position possible for Maloney dilators.
  • Initial Dilator Size: Based on the estimated stricture diameter.

Mechanical Dilation

  • Maloney Dilator: Passed blindly after endoscope removal. Assess for resistance and blood to gauge success.
  • Guidewire-Based Dilators: Passed over the guidewire; the guidewire is fed through the endoscope into the stomach.

Balloon Dilation (TTS)

  • Procedure: Passed through the endoscope channel, with inflation under direct visualization or fluoroscopy.
  • Observation: Fluoroscopic observation helps assure maximum diameter achievement.
  • Dilation Protocol: Typically two to three dilations per session, each lasting 30 to 60 seconds.

Number of Dilations Per Session

  • Guidelines: Limiting the number of dilations and incremental increases helps reduce adverse effects.
  • Bougie Dilators: No more than three dilators per session, increasing luminal stenosis by no more than 6 French.
  • Balloon Dilators: Limit to three incremental inflations.

Repeated Sessions

  • Frequency: Depends on initial success and patient response.
  • Shrinkage Consideration: Reassess stricture diameter as shrinkage is common.

Safety of Mucosal Biopsy Prior to Dilation

  • General Practice: Biopsies are typically performed after dilation, but doing them beforehand is likely safe.

Post-Dilation Acid Control

Proton Pump Inhibitors (PPIs)

  • Purpose: Decrease the risk of stricture recurrence post-dilation.
  • Effectiveness: PPIs are more effective than H2 antagonists in reducing the need for subsequent dilation in patients with peptic strictures.
  • Practice: Omeprazole 20 mg twice daily for one year is common, increasing to 40 mg if necessary.
  • Importance of Adequate Dilation: Even with PPI treatment, ensuring proper dilation is crucial.

Studies on PPIs

  • Example: In a study comparing omeprazole and ranitidine, omeprazole-treated patients required fewer repeated dilation sessions and had improved dysphagia scores.
  • Stricture Diameter and Esophagitis: Dysphagia in peptic strictures relates to both stricture diameter and presence of esophagitis.

Ambulatory pH Monitoring

  • Use: For patients with recurrent peptic strictures despite PPI use.
  • Purpose: To ensure adequate acid suppression.

Surgical Consideration

  • Indication: Young patients with peptic strictures frequently requiring dilation or dependent on PPIs.

Refractory Strictures

Challenges in Management

  • Issue: Patients not achieving symptom relief despite intensive dilation and reflux therapy.
  • Surgical Candidacy: Often poor candidates for surgery, yet successful antireflux surgery depends on adequate preoperative dilation.

Self-Dilation

  • Suitability: For motivated patients with simple strictures, though risks exist.

Endoscopic Techniques

  • Corticosteroid Injections: Commonly used but with unestablished efficacy.
  • Removable Esophageal Stents: Another option, though with mixed experiences and potential risks.

Studies on Corticosteroids and Stents

  • Corticosteroid Injections: Showed a reduction in repeat dilation need.
  • Nonmetal Stents: Mixed results, with potential complications like stent migration and pain.
  • Metal Stents: Not recommended for benign strictures due to complications.

Prognosis

Prognosis of Esophageal Stricture

Overview

The prognosis of esophageal stricture is influenced by the cause of the stricture, timeliness of diagnosis and treatment, and the patient’s overall health.

Benign Esophageal Strictures

  • Treatment Outcome: Generally favorable with prompt treatment.
  • Common Treatment: Endoscopic dilation and long-term proton pump inhibitor (PPI) therapy.
  • Recurrence Risk: 10-30% chance of re-stenosis after dilation, possibly requiring additional procedures.

Malignant Esophageal Strictures

  • Prognostic Factors: Type and stage of cancer, and extent of tumor invasion.
  • Surgical Resection: Offers better prognosis in early stages, without lymph node or tissue invasion.
  • Palliative Stent Placement: Poor prognosis.

Complications

  • Risks of Untreated Strictures: Include food impaction, aspiration, asthma from aspiration, and severe chest pain.
  • Severe Complications: Untreated cases can lead to esophageal perforations, which are life-threatening.

Overall Outcome

  • Success Rate: Good-to-excellent outcomes in 77% of cases (range 43-90%).
  • Repeat Dilation Rate: Approximately 30%.

ICD

  • VIDEO
  • CONTENT
  • QUIZ
  • MATERIALS
  • Introduction
  • Epidemiology
  • Etiology
  • Pathogenesis
  • Signs and Symptoms
  • Diagnosis
  • Staging
  • Differential Diagnosis
  • Treatment
  • Dilation
  • Prognosis
  • ICD
  • Research

Introduction to Esophageal Stricture

Overview

Esophageal stricture refers to the abnormal narrowing of the esophageal lumen, leading to dysphagia, or difficulty swallowing. This condition arises from various causes, such as inflammation, fibrosis, or neoplasia, damaging the mucosal or submucosal layers of the esophagus. These strictures can be either benign or malignant, necessitating accurate diagnosis for effective management.

Etiology

The predominant cause of esophageal strictures in adults is benign peptic stricture, accounting for 70-80% of cases, typically associated with long-standing gastroesophageal reflux disease (GERD). The preventive use of proton pump inhibitors (PPIs) has reduced the incidence of peptic strictures. Other factors contributing to esophageal stricture include:

  • Acid peptic damage
  • Autoimmune disorders
  • Infectious diseases
  • Caustic substance ingestion
  • Congenital factors
  • Iatrogenic causes (medical interventions)
  • Medication-induced damage
  • Radiation therapy
  • Malignant growths
  • Idiopathic (unknown) causes

Pathophysiology and Prognosis

The development of an esophageal stricture is a gradual process. Its prognosis largely depends on the timely evaluation and management, along with the underlying cause of the stricture.

Management and Challenges

The primary treatment for benign esophageal strictures is esophageal dilation. However, this method carries a 10-30% risk of re-stenosis, or recurrence of the stricture. Recurrent strictures pose significant challenges, including increased risks and healthcare costs.

Epidemiology of Esophageal Stricture

Incidence and Prevalence

  • General Incidence: Esophageal stricture has an incidence rate of 1.1 per 10,000 person-years, with an increase in incidence observed with advancing age.
  • Study Findings: In one study, the overall incidence was reported as 11 per 100,000 individuals, with benign strictures at 8 per 100,000 and malignant strictures at 3 per 100,000.

Impact of Diagnostic Delay

  • Eosinophilic Esophagitis (EoE): The prevalence of esophageal stricture increases with delayed diagnosis, ranging from 17% within 0-2 years to 71% after 20 years.

Age-Related Variations

  • Children and Young Patients: Higher incidence of strictures due to caustic esophagitis or eosinophilic esophagitis.
  • Adults: Acid reflux, iatrogenic, or drug-induced esophagitis are more common causes.
  • Older Populations: Increased incidence of malignant strictures due to higher cancer prevalence.

Influence of GERD

  • GERD-Related Strictures: Approximately 7-23% of untreated GERD patients develop esophageal strictures.
  • GERD Prevalence: Affects about 40% of adults, with strictures in 7–23% of untreated cases.
  • Impact of Proton Pump Inhibitors: The incidence of benign esophageal stricture has decreased due to PPI use in GERD treatment.

Gender and Racial Distribution

  • Gender Differences: Higher risk in men under 60 years, but similar incidence in men and women after age 60.
  • Racial Predilection: No racial predilection has been identified for esophageal stricture.

Etiology of Esophageal Stricture

Intrinsic Diseases

  • Gastroesophageal Reflux Disease (GERD): The most common intrinsic cause, accounting for 70-80% of adult cases. Chronic reflux of stomach acid into the esophagus leads to inflammation, scarring, and eventually narrowing.
  • Eosinophilic Esophagitis: An allergic inflammatory condition causing esophageal narrowing.
  • Radiation Therapy: Can induce inflammation and scarring, leading to stricture.
  • Esophageal Varices Treatment: Procedures like banding or sclerotherapy may result in injury and stricture.
  • Caustic Ingestions: Corrosive substance ingestion leads to severe injury and stricture.
  • Esophageal Surgeries: Post-operative scarring can cause stricture.
  • Nasogastric Tube Use: Frequent use may cause injury and stricture.
  • Dermatologic Diseases: Rare conditions involving the esophagus.
  • Congenital Factors: Esophageal strictures and webs present from birth.

Extrinsic Diseases

  • Malignancies and Lymph Node Enlargement: Direct invasion or lymph node enlargement can compress the esophagus, causing stricture.

Disorders Affecting Esophageal Motility

  • Conditions that disrupt esophageal movement and lower esophageal sphincter function.

Pathogenesis of Esophageal Stricture

Inflammation and Fibrosis

  • GERD: Chronic regurgitation of gastric contents into the esophagus leads to inflammation and fibrosis of the esophageal mucosa, causing stricture. Contributing factors include esophageal dysmotility, lower esophageal sphincter (LES) tone impairment, transient LES relaxation, and delayed gastric emptying.
  • Eosinophilic Esophagitis (EoE): A chronic, T helper type 2 (Th2)–associated inflammatory disease marked by eosinophilic inflammation. Its pathogenesis involves environmental and genetic factors, with roles for eosinophils, mast cells, and cytokines like IL-5 and IL-13, often triggered by allergic sensitization to foods.
  • Caustic Ingestion: Ingesting toxic substances (like lye) severely damages the esophageal mucosa, leading to inflammation, necrosis, and subsequent fibrosis and stricture.

Neoplasia

  • Tumor Growth: Abnormal cell growth can cause stricture either through direct invasion of the esophageal lumen or extrinsic compression by enlarged lymph nodes or other structures.

Other Contributing Factors

  • Autoimmune Diseases
  • Infectious Diseases
  • Congenital Conditions
  • Iatrogenic Causes (medical interventions)
  • Medication-Induced Causes
  • Radiation-Induced Causes
  • Idiopathic Processes (unknown causes)

Signs and Symptoms of Esophageal Stricture

Common Symptoms

  • Dysphagia: Difficulty swallowing is the most common symptom.
  • Odynophagia: Painful swallowing.
  • Regurgitation: Food coming back up the throat from the stomach.
  • Heartburn: Frequent occurrence.
  • Throat Inflammation: Burning sensation in the throat.
  • Hiccupping/Burping: Frequent episodes.
  • Coughing/Choking: Especially during eating.
  • Weight Loss: Unintentional, due to difficulty in swallowing.
  • Drooling: Inability to swallow saliva efficiently.
  • Dehydration: Due to difficulty in swallowing liquids.

Diagnosis of Esophageal Stricture

Initial Evaluation

  • Medical History: Understanding symptoms like dysphagia, food sticking sensation, and heartburn.
  • Physical Examination: Bedside evaluation for signs indicative of esophageal stricture.

Diagnostic Tests

  • Esophagogastroduodenoscopy (EGD): A flexible tube with a camera is used to visualize the esophagus, stomach, and duodenum. It helps identify the stricture’s presence and location. Biopsies can be performed if needed.
  • Contrast-enhanced Esophagogram or Barium Swallow: Patient swallows a barium solution to coat the esophagus, making it visible on X-rays. This shows the size and location of the stricture.
  • Esophageal Manometry: Measures esophageal muscle pressure and coordination, detecting irregular peristalsis or muscle contractions.
  • Endoscopic Ultrasound (EUS): Useful particularly when biopsies are negative for malignancy but there’s suspicion of esophageal cancer.

Assessment of Esophageal Motility Disorders

  • It’s important to evaluate for any associated esophageal motility disorders, as they can influence the management approach for esophageal strictures.

Differential Diagnosis of Esophageal Stricture

Key Conditions to Consider

  • Achalasia: A disorder affecting esophageal motility and relaxation of the lower esophageal sphincter.
  • Esophageal Motility Disorders: Abnormal muscle contractions in the esophagus causing dysphagia.
  • Esophagitis: Inflammation of the esophagus, which can mimic symptoms of stricture.
  • Schatzki Ring: A thin ring of tissue in the lower esophagus that can cause swallowing difficulties.
  • Plummer-Vinson Syndrome: Characterized by iron deficiency anemia, dysphagia, and esophageal webs.
  • Diffuse Esophageal Spasm: Intermittent contractions of the esophagus leading to swallowing issues.
  • Systemic Sclerosis: An autoimmune disease that can involve esophageal dysfunction.
  • Zenker’s Diverticulum: A pouch that can form in the throat, near the esophagus, causing swallowing difficulties.
  • Esophageal Carcinoma: Cancer of the esophagus, presenting with progressive dysphagia.
  • Stroke: Neurological event that can affect swallowing.
  • Motor Disorders: Such as Myasthenia Gravis, affecting muscle strength and function.
  • Gastroesophageal Reflux Disease (GERD): Chronic acid reflux causing esophageal irritation.
  • Esophageal Web: Thin membranes across the esophagus, causing obstruction.

Treatment Options for Esophageal Stricture

Esophageal Dilation

  • Procedure: Widening the narrowed area using a balloon or dilator.
  • Method: Placement of the dilator using an endoscope, often performed during endoscopy.

Steroid Injections

  • Purpose: To reduce inflammation and prevent recurrence of the stricture.
  • Application: Administered alongside dilation procedures.

Stent Placement

  • Use: Primarily for palliation of malignant esophageal strictures.
  • Function: Keeps the esophagus open to facilitate swallowing, suited for patients with limited expected survival.

Incisional Therapy

  • Indication: For refractory strictures that do not respond to dilation.
  • Method: Cutting scar tissue to open the stricture.

Surgical Resection

  • Consideration: In cases involving cancer, to remove cancerous tissue.
  • Goal: To alleviate the stricture caused by tumor growth.

Medical Management

  • Treatment: Use of proton pump inhibitors (PPIs) for underlying conditions like GERD.
  • Objective: To prevent further damage and recurrence of the stricture.

Esophageal Dilation

Evaluation Prior to Esophageal Dilation

Barium Studies

  • General Use: Not typically required before endoscopy in suspected esophageal stricture cases.
  • Specific Cases: Recommended for complex strictures, such as those from radiation therapy or caustic ingestion.
  • Goals: Identify stricture location, length, number, esophageal lumen diameter, and any associated pathology.
  • Purpose: Helps in selecting dilating techniques, estimating session numbers, and informing patients about risks.

Endoscopy

  • Role in Malignancy: Necessary for diagnosis if barium studies suggest malignancy.
  • Typical Procedure: Often performed along with dilation in the initial session.

Contraindications to Dilation

  • Acute Conditions: Avoid in acute or incompletely healed esophageal perforation.
  • Malignancy Concerns: Postpone if the stricture might be malignant, until confirmed benign.
  • Comorbid Illnesses: Consider risks in patients with bleeding disorders or severe pulmonary/cardiovascular disease.
  • Special Cases: Use caution in patients with pharyngeal or cervical deformities, recent surgery, large thoracic aneurysms, or impacted food bolus.
  • Eosinophilic Esophagitis: Extreme care needed due to higher perforation risk.

Types of Esophageal Dilators

Mechanical Dilators

  • Categories: Push-type (Bougie) and balloon dilators.
  • Mechanism: Increase esophageal lumen size through stretching or splitting.
  • Types:
    • Freely Passed Dilators: Maloney (common, tapered tip, multiple sizes, mercury or tungsten-filled), Hurst (rounded tip, less common). Pasted-20231202-150932.svg
    • Guidewire-Assisted Dilators: Savary-Gilliard (plastic, tapered, multiple sizes), American Dilatation System, Eder-Puestow olive dilators (metal, less used). Pasted-20231202-151058.svg
    • Flexible Bougie: Transparent, over endoscope, allows sequential dilation.

Balloon Dilators

  • Types: Through-the-scope (TTS) and over-the-guidewire (OTW).
  • Features: Greater radial force, retain maximum diameter predictably.
  • Sizes: Initially in 2 mm increments, newer TTS balloons expand to three diameters at 1.0 to 1.5 mm increments.

Therapeutic Approach to Esophageal Stricture

Approach Based on Stricture Characteristics

  • Dependency: Treatment varies depending on the stricture’s nature and the endoscopist’s experience.
  • Simple vs. Complex: Simple strictures differ significantly from complex ones in terms of management.

Treatment of Simple Strictures

  • Characteristics: Typically associated with prolonged reflux esophagitis, they are smooth, short, straight, and located in the distal esophagus.
  • Diameter Consideration: Can be traversed with an endoscope (>10 mm in diameter).
  • Dilation Techniques: Use of Maloney dilators, balloon dilators, or mechanical dilators passed over a guidewire, based on preference.

Treatment of Complex Strictures

  • Nature: Long, narrow, tortuous, or associated with other complications like hiatal hernias or diverticula.
  • Risk Mitigation: Use of a guidewire-based system or a balloon dilator to prevent complications like esophageal perforation.
  • Combination Therapy: Initial dilation with guidewire or balloon dilators, followed by Maloney dilators for further sessions if feasible.

Special Considerations

  • Proximal Strictures: May require a barium swallow for detailed assessment. Treated with guidewire-based dilators, sometimes under fluoroscopic guidance.
  • Eosinophilic Esophagitis (EoE): Dilation as adjunctive therapy after medical treatment fails. Increased risk of tearing and perforation. Both mechanical and balloon dilators are used without a clear superiority. Aim for symptomatic relief with a maximum diameter of 13 to 14 mm.

Perforation Risk in EoE

  • Systematic Review Findings: Relative risk of perforation in EoE dilation is 0.1 percent, similar to other indications.

Dilation Technique

Procedure Overview

  • Setting: Performed as an ambulatory procedure using conscious sedation and topical pharyngeal anesthesia.
  • Patient Preparation: Fasting, avoidance of antiplatelet agents and anticoagulants, no longer requiring antibiotic prophylaxis.
  • Positioning: Left lateral decubitus position; seated position possible for Maloney dilators.
  • Initial Dilator Size: Based on the estimated stricture diameter.

Mechanical Dilation

  • Maloney Dilator: Passed blindly after endoscope removal. Assess for resistance and blood to gauge success.
  • Guidewire-Based Dilators: Passed over the guidewire; the guidewire is fed through the endoscope into the stomach.

Balloon Dilation (TTS)

  • Procedure: Passed through the endoscope channel, with inflation under direct visualization or fluoroscopy.
  • Observation: Fluoroscopic observation helps assure maximum diameter achievement.
  • Dilation Protocol: Typically two to three dilations per session, each lasting 30 to 60 seconds.

Number of Dilations Per Session

  • Guidelines: Limiting the number of dilations and incremental increases helps reduce adverse effects.
  • Bougie Dilators: No more than three dilators per session, increasing luminal stenosis by no more than 6 French.
  • Balloon Dilators: Limit to three incremental inflations.

Repeated Sessions

  • Frequency: Depends on initial success and patient response.
  • Shrinkage Consideration: Reassess stricture diameter as shrinkage is common.

Safety of Mucosal Biopsy Prior to Dilation

  • General Practice: Biopsies are typically performed after dilation, but doing them beforehand is likely safe.

Post-Dilation Acid Control

Proton Pump Inhibitors (PPIs)

  • Purpose: Decrease the risk of stricture recurrence post-dilation.
  • Effectiveness: PPIs are more effective than H2 antagonists in reducing the need for subsequent dilation in patients with peptic strictures.
  • Practice: Omeprazole 20 mg twice daily for one year is common, increasing to 40 mg if necessary.
  • Importance of Adequate Dilation: Even with PPI treatment, ensuring proper dilation is crucial.

Studies on PPIs

  • Example: In a study comparing omeprazole and ranitidine, omeprazole-treated patients required fewer repeated dilation sessions and had improved dysphagia scores.
  • Stricture Diameter and Esophagitis: Dysphagia in peptic strictures relates to both stricture diameter and presence of esophagitis.

Ambulatory pH Monitoring

  • Use: For patients with recurrent peptic strictures despite PPI use.
  • Purpose: To ensure adequate acid suppression.

Surgical Consideration

  • Indication: Young patients with peptic strictures frequently requiring dilation or dependent on PPIs.

Refractory Strictures

Challenges in Management

  • Issue: Patients not achieving symptom relief despite intensive dilation and reflux therapy.
  • Surgical Candidacy: Often poor candidates for surgery, yet successful antireflux surgery depends on adequate preoperative dilation.

Self-Dilation

  • Suitability: For motivated patients with simple strictures, though risks exist.

Endoscopic Techniques

  • Corticosteroid Injections: Commonly used but with unestablished efficacy.
  • Removable Esophageal Stents: Another option, though with mixed experiences and potential risks.

Studies on Corticosteroids and Stents

  • Corticosteroid Injections: Showed a reduction in repeat dilation need.
  • Nonmetal Stents: Mixed results, with potential complications like stent migration and pain.
  • Metal Stents: Not recommended for benign strictures due to complications.

Prognosis of Esophageal Stricture

Overview

The prognosis of esophageal stricture is influenced by the cause of the stricture, timeliness of diagnosis and treatment, and the patient’s overall health.

Benign Esophageal Strictures

  • Treatment Outcome: Generally favorable with prompt treatment.
  • Common Treatment: Endoscopic dilation and long-term proton pump inhibitor (PPI) therapy.
  • Recurrence Risk: 10-30% chance of re-stenosis after dilation, possibly requiring additional procedures.

Malignant Esophageal Strictures

  • Prognostic Factors: Type and stage of cancer, and extent of tumor invasion.
  • Surgical Resection: Offers better prognosis in early stages, without lymph node or tissue invasion.
  • Palliative Stent Placement: Poor prognosis.

Complications

  • Risks of Untreated Strictures: Include food impaction, aspiration, asthma from aspiration, and severe chest pain.
  • Severe Complications: Untreated cases can lead to esophageal perforations, which are life-threatening.

Overall Outcome

  • Success Rate: Good-to-excellent outcomes in 77% of cases (range 43-90%).
  • Repeat Dilation Rate: Approximately 30%.

Leave a Comment

Your email address will not be published. Required fields are marked *